Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib (Q46504066)
Jump to navigation
Jump to search
scientific article published on 5 April 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib |
scientific article published on 5 April 2012 |
Statements
1 reference
Evaluation of circulating tumor cells and circulating tumor DNA in non-small cell lung cancer: association with clinical endpoints in a phase II clinical trial of pertuzumab and erlotinib (English)
1 reference
1 reference
Lukas C Amler
1 reference
Andrea Pirzkall
1 reference
Elizabeth A Punnoose
1 reference
Siminder Atwal
1 reference
Weiqun Liu
1 reference
Rajiv Raja
1 reference
Brett G M Hughes
1 reference
Garret M Hampton
1 reference
5 April 2012
1 reference
18
1 reference
8
1 reference
2391-2401
1 reference
Identifiers
1 reference